Medtronic Q4 FY26: where the revenue came from and where it went
The whole income statement of Medtronic for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 24 – Apr 24, 2026
- Reported
- Jun 18, 2026
Revenue$9.81B
+10% year over year
Gross profit$6.41B
65% margin
Operating profit$1.87B
19% margin
Net profit$1.24B
13% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 9.81 | 100% | +10% |
| Cardiovascular | 3.80 | 39% | +14% |
| Neuroscience group | 2.75 | 28% | +5% |
| Medical surgical | 2.39 | 24% | +8% |
| Diabetes group | 0.84 | 9% | +15% |
| Other and unallocated | 0.04 | 0% | |
| Cost of revenue | −3.40 | 35% | |
| Gross profit | 6.41 | 65% margin | +1pp |
| SG&A | −3.06 | 31% | +1pp |
| Other | −1.48 | 15% | +0pp |
| Operating profit | 1.87 | 19% margin | +3pp |
| Interest & other costs | −0.05 | ||
| Tax | −0.58 | ||
| Net profit | 1.24 | 13% margin | +1pp |
11 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest